On the other hand, radiotherapy may upregulate PD-L1 expression in tumor tissues and exert a negative immunomodulatory effect, which can be counteracted by anti-PD-1/PD-L1 antibodies through their pathways of action 44,45(Fig. 2). Here, CD274 is linked to neoplasm.